Bond.az White LogoBond.az Black Logo

Nvidia Stock Rises Ahead of Computex Keynote

Lynx Equity sees Nvidia stock gaining on Computex keynote catalyst. Stock returned 53.96% over past year.

Michael Brown
ByMichael Brown- Senior Editor
|
0

Lynx Equity issued a positive outlook on Nvidia Corp. (NASDAQ:NVDA) ahead of the company's Computex keynote, citing the event as a potential catalyst.

Nvidia shares have declined since the recent earnings event, while other AI semiconductor stocks reached new highs. Despite the pullback, the stock has delivered a 53.96% return over the past year and trades at a P/E ratio of 32.78 with a low PEG ratio of 0.29.

Lynx Equity expects the CEO to address the stock's recent underperformance during the keynote scheduled for Sunday night. Details on the $20 billion revenue and $200 billion total addressable market for CPUs related to Agentic AI, the ramp trajectory for the Rubin platform within the $1 trillion GPU AI systems outlook, and a long-term outlook for the networking segment are anticipated.

The firm noted that competition from application-specific integrated circuits at hyperscalers has weighed on the stock's valuation. The CEO was reported hosting a dinner with executives from Foxconn, TSMC, Delta Electronics, Compal, and Pegatron.

Lynx Equity has maintained a cautious stance for nearly a year but sees risk-reward tilting to the upside heading into Computex. For deeper analysis, access Nvidia's Pro Research Report on Bond.az.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
731

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
Nvidia Stock Rises Ahead of Computex Keynote | Bond.az